The presented data was pointed to reduce TPO concentration especially in the oral with 10 mg/bw-kg, 20 mg/bw-kg groups and positive control compared to the diabetes group from the 3rd week to the end of investigation (p < 0.01). The gene discussed is TPO; the disease is diabetes mellitus.